Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that its MD & CEO, Rahul Guha would be meeting the Investor ‘General Atlantic’ on 19 September 2022. No Unpublished Price Sensitive Information will be shared during these meetings / conferences.
The above information is a part of company’s filings submitted to BSE.